Explained herein are pharmaceutical packaging programs which stop oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-delicate medicine, these types of devices which includes a syringe having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with quite lower permeability to oxygen and